Status:
TERMINATED
Quality of Life Outcomes in Spinal Cord Stimulation
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Neuropathic Pain
Low Back Pain
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators will be evaluating quality of life outcomes in patients who are undergoing routine spinal cord stimulator implant for uncontrolled pain. Patients will be evaluated pre and post-opera...
Detailed Description
This is a prospective cohort study for patients who will be undergoing implantation of spinal cord stimulator for pain. All patient will have implantation done at University Hospital Newark or Newark ...
Eligibility Criteria
Inclusion
- Patients with neuropathic pain or axial back pain that is not controlled by oral analgesics, opioids, and has failed conservative management.
- Ages 18-90 with no ethnicity or gender predilections.
Exclusion
- Patients who have spinal cord injury, multiple stimulator revisions, DRG stimulators, intrathecal pain pumps, complex regional pain syndrome, previous spinal cord stimulator implant, mechanical instability requiring fusion, myelopathy, psychological condition precluding them from complying with therapy, illegal drug abuse including heroin, cocaine, and illegally obtained prescription pills, or have previously been or are currently involved in litigation for medical malpractice.
Key Trial Info
Start Date :
October 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2018
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03249922
Start Date
October 27 2017
End Date
July 22 2018
Last Update
July 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurologic Institute of New Jersey
Newark, New Jersey, United States, 07103